Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 — a systematic review and meta-analyses; BMC Infectious Diseases; Vol. 25

Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 — a systematic review and meta-analyses; BMC Infectious Diseases; Vol. 25

מידע ביבליוגרפי
Parent link:BMC Infectious Diseases.— .— New York: BioMed Central (Springer Nature)
Vol. 25.— 2025.— Article number 719, 22 p.
מחברים אחרים: Babatunde F. Fatoke, Lal Hui Amrit, Saqib M. Muhammad, Vashisth M. Mrinal, Olaide A. S. Aremu Stephen, Aremu D. O. Dorcas Oluwakemi, Aremu D. B. Deborah Bukola
סיכום:Title screen
The COVID-19 pandemic has posed significant challenges to global health, with type 2 diabetes mellitus (T2DM) emerging as a key risk factor for adverse outcomes. This study systematically reviews and quantifies the association between T2DM and COVID-19 outcomes, including mortality, severity, and need for mechanical ventilation
Текстовый файл
שפה:אנגלית
יצא לאור: 2025
נושאים:
COVID-19
Type 2 Diabetes Mellitus
Mortality
Disease severity
Mechanical ventilation
Meta-analysis
электронный ресурс
труды учёных ТПУ
גישה מקוונת:https://doi.org/10.1186/s12879-025-11089-w
פורמט: אלקטרוני Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=682958

פריטים דומים

פריטים דומים